scholarly journals Shaping proteostasis at the cellular, tissue, and organismal level

2017 ◽  
Vol 216 (5) ◽  
pp. 1231-1241 ◽  
Author(s):  
Ambre J. Sala ◽  
Laura C. Bott ◽  
Richard I. Morimoto
Keyword(s):  
Cellular Tissue ◽  
Degenerative Diseases ◽  
Cell Type ◽  
Therapeutic Approaches ◽  
New Therapeutic Approaches ◽  
Precise Understanding ◽  
Systemic Level ◽  
Cell Type Specific ◽  
Multicellular Organisms ◽  
Pn Regulation

The proteostasis network (PN) regulates protein synthesis, folding, transport, and degradation to maintain proteome integrity and limit the accumulation of protein aggregates, a hallmark of aging and degenerative diseases. In multicellular organisms, the PN is regulated at the cellular, tissue, and systemic level to ensure organismal health and longevity. Here we review these three layers of PN regulation and examine how they collectively maintain cellular homeostasis, achieve cell type-specific proteomes, and coordinate proteostasis across tissues. A precise understanding of these layers of control has important implications for organismal health and could offer new therapeutic approaches for neurodegenerative diseases and other chronic disorders related to PN dysfunction.

scholarly journals The Effect of the Combinations of 5-Fluorouracil, Leptin and Leptin Antagonist in Glioblastoma

Proceedings ◽  
2019 ◽  
Vol 40 (1) ◽  
pp. 19
Author(s):  
Taşpinar ◽  
Denizler ◽  
Taşpinar
Keyword(s):  
Brain Tumor ◽  
Cell Lines ◽  
Poor Prognosis ◽  
Leptin Receptor ◽  
Cell Type ◽  
Therapeutic Approaches ◽  
Cytotoxic Effects ◽  
New Therapeutic Approaches ◽  
Aggressive Form ◽  
The Relationship

Glioblastoma (GB) is the most aggressive form of brain tumor and resistant to chemotherapy. New therapeutic approaches are needed to improve the efficacy of chemotherapy. It was reported that there may be a relationship between obesity and poor prognosis in GB treatment. However, there is no study investigating the relationship between leptin, leptin receptor and chemotherapy in GB. The aim of this study was to investigate the cytotoxic effects of 5-Fluorouracil (5-FU) in the treatment of GB in the presence of leptin and leptin receptor antagonist SHLA. LN-405, T98G and U373-MG GB cell lines were used for this purpose. The cytotoxic effects of these molecules in both single and combination were determined by MTT. The sensitivities of GB cell lines to 5-FU were found to be different and leptin and SHLA had no cytotoxic effects in GB cells. It was determined that leptin increased 5-FU toxicity by 8–57% depending on 5-FU dose and cell type in all three cell lines in combination groups. A similar effect was detected in combinations of SHLA with 5-FU (6–58%). This is the first study to show that combinations of 5-FU with leptin and SHLA increase the cytotoxicity of 5-fluorouracil in cancer.

scholarly journals Complex transcriptional regulation and independent evolution of fungal-like traits in a relative of animals

eLife ◽  
2015 ◽  
Vol 4 ◽  
Author(s):  
Alex de Mendoza ◽  
Hiroshi Suga ◽  
Jon Permanyer ◽  
Manuel Irimia ◽  
Iñaki Ruiz-Trillo
Keyword(s):  
Cell Types ◽  
Cell Type ◽  
Dynamic Regulation ◽  
Transcriptional Dynamics ◽  
Genome Regulation ◽  
A Cell ◽  
Cell Type Specific ◽  
Gene Modules ◽  
Multicellular Organisms ◽  
Different Cell Types

Cell-type specification through differential genome regulation is a hallmark of complex multicellularity. However, it remains unclear how this process evolved during the transition from unicellular to multicellular organisms. To address this question, we investigated transcriptional dynamics in the ichthyosporean Creolimax fragrantissima, a relative of animals that undergoes coenocytic development. We find that Creolimax utilizes dynamic regulation of alternative splicing, long inter-genic non-coding RNAs and co-regulated gene modules associated with animal multicellularity in a cell-type specific manner. Moreover, our study suggests that the different cell types of the three closest animal relatives (ichthyosporeans, filastereans and choanoflagellates) are the product of lineage-specific innovations. Additionally, a proteomic survey of the secretome reveals adaptations to a fungal-like lifestyle. In summary, the diversity of cell types among protistan relatives of animals and their complex genome regulation demonstrates that the last unicellular ancestor of animals was already capable of elaborate specification of cell types.

scholarly journals Toward a unified theory of aging and regeneration

2019 ◽  
Vol 14 (9) ◽  
pp. 867-886 ◽  
Author(s):  
Michael D West ◽  
Hal Sternberg ◽  
Ivan Labat ◽  
Jeffrey Janus ◽  
Karen B Chapman ◽  
...  
Keyword(s):  
Gene Expression ◽  
Tissue Regeneration ◽  
Antagonistic Pleiotropy ◽  
Unified Theory ◽  
Degenerative Diseases ◽  
Therapeutic Approaches ◽  
Regenerative Capacity ◽  
New Therapeutic Approaches ◽  
Age Related ◽  
Theory Of Aging

Growing evidence supports the antagonistic pleiotropy theory of mammalian aging. Accordingly, changes in gene expression following the pluripotency transition, and subsequent transitions such as the embryonic–fetal transition, while providing tumor suppressive and antiviral survival benefits also result in a loss of regenerative potential leading to age-related fibrosis and degenerative diseases. However, reprogramming somatic cells to pluripotency demonstrates the possibility of restoring telomerase and embryonic regeneration pathways and thus reversing the age-related decline in regenerative capacity. A unified model of aging and loss of regenerative potential is emerging that may ultimately be translated into new therapeutic approaches for establishing induced tissue regeneration and modulation of the embryo-onco phenotype of cancer.

IFIH1-deficiency results in a cell-type specific alteration of autophagic activity in response to S. typhimurium

2017 ◽  
Vol 55 (05) ◽  
pp. e28-e56
Author(s):  
S Macheiner ◽  
R Gerner ◽  
A Pfister ◽  
A Moschen ◽  
H Tilg
Keyword(s):  
Cell Type ◽  
A Cell ◽  
Cell Type Specific ◽  
Autophagic Activity ◽  
Specific Alteration

New therapeutic approaches for polymyositis and dermatomyositis

2011 ◽  
Vol 152 (39) ◽  
pp. 1552-1559 ◽  
Author(s):  
Katalin Dankó ◽  
Melinda Vincze
Keyword(s):  
Immunosuppressive Agents ◽  
Inflammatory Myopathy ◽  
Proximal Muscle ◽  
Therapeutic Approaches ◽  
First Line ◽  
New Therapeutic Approaches ◽  
Remission Period ◽  
Immune Mediated ◽  
Systemic Manifestations ◽  
Line Of Therapy

Inflammatory myopathies are chronic, immune-mediated diseases characterized with progressive proximal muscle weakness. They encompass a variety of syndromes with protean manifestations. The aims of therapy are to increase muscle strength, prevent the development of contractures, and to manage the systemic manifestations of the disease. This is a complex treatment which requires routine and wide knowledge. The most important task is to recognize the disease and guide the patient to immunologic center. Although the first line of therapy continues to include corticosteroids, there are a multitude of agents available for treating patients with myositis. There are several different immunosuppressive agents which may be applied alone or in combination with each other, as well as an increasing number of novel and exciting biologic agents targeting molecules participating in the pathogenesis of inflammatory myopathy. Physiotherapy and rehabilitation in the remission period may significantly improve the functional outcome of patients with these disorders. Orv. Hetil., 2011, 152, 1552–1559.

Sign in / Sign up

Export Citation Format

Share Document